Tag:
Ascent Therapeutics
Latest Headlines
Latest Headlines
Renamed Anchor in talks for $30M round, new pact
The fledgling Cambridge, MA-based Ascent Therapeutics is opening up a new chapter in the company's development. It's changing its name, focusing on late-stage discussions for a new licensing pact
Fledgling Ascent scores $200M Novartis pact
Three weeks after reeling in a $19 million venture round, Ascent Therapeutics announced a licensing option deal through the Novartis Option Fund worth up to $200 million in fees and milestones.
